Pirfeheal
✅ Zmniejsza stan zapalny
✅ Alleviates pain effectively
✅ Convenient tablet format
✅ Improved pain relief
contains Pirfenidone
✓ Zweryfikowany medycznie przez Morgan Ellis — Badacz farmaceutyczny · 8 lat doświadczenia · Ostatnia weryfikacja: maj 2026
⚡ Quick Answer — What is Pirfeheal?
Pirfeheal zawiera pirfenidone, an oral anti-fibrotic used for idiopathic pulmonary fibrosis (IPF) — a progressive scarring lung disease. Pirfenidone reduces the rate of lung function decline (FVC) and may improve survival in IPF, slowing disease progression. It is taken three times daily with meals to minimise GI side effects, with planned dose escalation over 14 days. Manufactured by Healing Pharma at WHO-GMP certified facilities. Same active drug as international brand Esbriet (Roche).
📦 Każde zamówienie jest objęte naszą Reshipment Assurance Policy — jeśli Twoja przesyłka nie dotrze w ciągu 20 dni roboczych, wysyłamy ją ponownie.
Dlaczego warto zamawiać z MedsBase
Nasze leki generyczne pochodzą od producentów posiadających certyfikat WHO-GMP i są wysyłane na cały świat w dyskretnym, zwykłym opakowaniu — bez nazwy leku na zewnątrz przesyłki. Płatności kartami są kierowane przez regulowanego procesora (opis wyciągu zawiera nazwę regulowanego procesora płatności — nigdy “MedsBase” ani żadnej nazwy leku). Akceptujemy również kryptowaluty i przelewy bankowe SEPA. Każde zamówienie jest objęte naszą Reshipment Assurance Policy.
What Is Pirfeheal?
Pirfeheal is an oral anti-fibrotic / anti-inflammatory pyridone derivative. Pirfenidone is one of two drugs licensed for IPF (the other is nintedanib / Ofev). Both slow disease progression but do not cure or reverse fibrosis. Pirfenidone is also used off-label for other interstitial lung diseases with fibrotic phenotypes.
How Does Pirfeheal Work?
Pirfenidone has multiple mechanisms relevant to pulmonary fibrosis:
- Reduces TGF-β-driven fibroblast proliferation and collagen synthesis
- Suppresses TNF-α and IL-1β inflammatory signalling
- Inhibits epithelial-mesenchymal transition (EMT) — a key driver of fibrosis
- Reduces oxidative stress via free-radical scavenging
The clinical benefit (CAPACITY, ASCEND trials) is a 50% reduction in lung-function decline rate over 12 months. Some meta-analyses show survival benefit.
— wzmacnia normalną odpowiedź fizjologiczną, a nie wywołuje ją sztucznie.
- Idiopathic pulmonary fibrosis (IPF) — first-line slow-progression therapy alongside nintedanib
- Other progressive pulmonary fibrosis (interstitial lung disease with fibrotic phenotype) — off-label use
- Pulmonary fibrosis post-COVID-19 — emerging research
Pirfeheal Dosage
| Faza | Dawka | Częstotliwość |
|---|---|---|
| Days 1–7 (titration) | 200 mg | Three times daily with food |
| Days 8–14 (titration) | 400 mg | Three times daily with food |
| Day 15+ (maintenance) | 600 mg (3 × 200 mg) | Three times daily with food |
| Niewydolność wątroby / nerek | Reduce dose 50% | Three times daily |
Side Effects of Pirfeheal
- Nausea, dyspepsia, anorexia (commonest — taking with full meal helps)
- Photosensitive rash (avoid sun exposure; SPF 50+ daily)
- Zmęczenie
- Zawroty głowy, ból głowy
- Biegunka
- Mild liver enzyme elevation
Poważne — przerwij i zasięgnij pomocy:
- Severe rash, especially photodistributed
- Hepatitis (jaundice, dark urine, pale stools, RUQ pain)
- Severe weight loss (>5%)
- Severe persistent vomiting
Ostrzeżenia i środki ostrożności
- Fotowrażliwość: avoid prolonged sun exposure; wear SPF 50+ broad-spectrum sunscreen daily.
- Liver function monitoring: baseline LFTs, then every month for 6 months, every 3 months thereafter.
- Take with full meals to reduce GI side effects and slow absorption (which lessens nausea).
- Smoking reduces pirfenidone exposure by ~50% — strongly advise smoking cessation.
- CYP1A2 inhibitors (fluvoxamine, ciprofloxacin) raise levels significantly — avoid or reduce dose.
- Ciąża i karmienie piersią: przeciwwskazane.
Przeciwwskazania
- Hypersensitivity to pirfenidone
- Ciężka niewydolność wątroby (Child-Pugh C)
- End-stage renal disease (CrCl <30 ml/min) on dialysis
- Concomitant fluvoxamine
- Ciąża
Interakcje lekowe
| Lek oddziałujący | Efekt | Co robić |
|---|---|---|
| Fluvoxamine (potent CYP1A2 inhibitor) | 4× increase in pirfenidone levels | Przeciwwskazane |
| Ciprofloksacynę | 60% increase in pirfenidone levels | Avoid or halve pirfenidone dose |
| Smoking (induces CYP1A2) | ~50% reduction in levels | Smoking cessation strongly advised |
| Strong CYP1A2 inducers (rifampicin) | Reduce levels significantly | Unikać |
Przechowywanie
- Przechowuj w temperaturze poniżej 25°C in a cool, dry place away from direct sunlight.
- Keep in original packaging until use to protect from moisture and light.
- Do not use after the expiry date printed on the strip.
- Przechowywać w miejscu niedostępnym dla dzieci.
Powiązane alternatywy w MedsBase
- Budecort Inhaler — budesonide ICS for chronic lung disease
- Tiova Inhaler — tiotropium for chronic lung disease
- Unicontin-E — theophylline ER for severe lung disease
- Mucinac Effervescent — N-acetylcysteine antioxidant
- Rofaday — roflumilast for severe COPD
Najczęściej zadawane pytania
Will pirfenidone cure my IPF?
No — pirfenidone slows disease progression but does not cure or reverse pulmonary fibrosis. Most patients experience continued slow lung-function decline; a smaller subset have stable disease for years.
Jak szybko działa?
Reduction in FVC decline rate is measurable at 6–12 months in trials. Symptom benefit is harder to perceive — the goal is preventing worsening.
Why do I have to take it three times a day?
Pirfenidone has a short half-life (~3 hours). Three-times-daily dosing maintains steady tissue levels. Always take with food to minimise nausea.
Why the rash?
Pirfenidone is photosensitising — UV exposure can cause sunburn-like reactions on exposed skin. Daily broad-spectrum SPF 50+ sunscreen, sun-protective clothing, and avoiding peak UV hours largely prevent it.
Can I take pirfenidone with nintedanib (Ofev)?
Combination therapy is being studied (INJOURNEY pilot). Routine combination is not yet standard outside clinical trials. Discuss with your specialist.
Why must I monitor liver tests?
About 4% of patients develop liver enzyme elevation in trials. Monthly LFTs for the first 6 months catch this early — dose reduction or temporary stop usually resolves it.
Can I drink alcohol on pirfenidone?
Alcohol can amplify nausea and may stress the liver. Moderate alcohol may be acceptable; heavy drinking is not.
How long do I need to take pirfenidone?
Indefinitely, as long as you tolerate it and the disease has not progressed to end-stage. Stopping leads to resumption of faster lung-function decline.
Co zrobić, jeśli pominię dawkę?
Take it as soon as you remember unless the next dose is due. Never double up.
Więcej opcji w leczeniu astmy/POChP
Ranking według liczby ostatnich zamówień MedsBase — co wybierają inni klienci w tej kategorii.
| Moc | 200 mg |
|---|---|
| Ilość | 90 Tablet/s, 180 Tablet/s, 270 Tablet/s |
| Postać farmaceutyczna | Tabletka/s |
| Producent | Healing Pharma |
| Leczenie | Idiopathic pulmonary fibrosis |
| Marka generyczna | Pirfenidone |
Pirfeheal
Pytania i odpowiedzi
Pirfeheal
Produkty powiązane
Opinie
Nie ma jeszcze opinii